期刊
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
卷 40, 期 1, 页码 56-66出版社
SAGE PUBLICATIONS LTD
DOI: 10.1177/147323001204000106
关键词
CELECOXIB; NON-STEROIDAL ANTI-INFLAMATORY DRUGS; CERVICAL CANCER; HELA CELLS; RADIOSENSITIVITY; CYCLO-OXYGENASE-2; VASCULAR ENDOTHELIAL GROWTH FACTOR C
资金
- Scientific and Technological Project of Luoyang, China [0801059A]
OBJECTIVE: The effects of celecoxib, a selective cyclo-oxygenase-2 (COX-2) inhibitor, on He La cervical cancer cell growth and radiosensitivity were investigated. METHODS: Cytotoxicity was quantified using a 3-(4,5-dimethyl-thiazol-2-yl)-2,5-diphenyltetrazolium assay and effects on radiosensitivity were assessed using the lethal dose, quasi-threshold dose, fraction surviving after 2 Gy irradiation and the radiosensitization ratio (SER, based on average lethal dose) determined using a single-hit multitarget model. RESULTS: Celecoxib inhibited He La cell proliferation in a concentration- and time-dependent manner, with a half-maximal inhibitory concentration at 72 h of 44 mu mol/l. Treatment with 20 mu mol/l celecoxib for 72 h before irradiation was associated with an SER of 2.01. The SER of irradiated cells was 2.41 when treated with 40 mu mol/l celecoxib before irradiation, 1.89 when treated simultaneously and 1.44 when treated after irradiation. Celecoxib down-regulated COX-2 and vascular endothelial growth factor C (VEGF-C) expression evaluated immunohistochemically. CONCLUSION: Celecoxib pretreatment radiosensitizes He La cells via a mechanism dependent on down-regulation of COX-2 and VEGF-C.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据